SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Metabasis Therapeutics, Inc. Announces Merck & Co., Inc. Has Selected a Lead AMPK Activator for Late Preclinical Development; Triggers $6 Million Payment to Metabasis